InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
9%
T+90 mean return
-21.3%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Ciaramella Giuseppe, Président et CSO. Insider active across 1 company, notably Beam Therapeutics Inc.. In total, 31 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €6.1m. History available since 28 June 2021. The latest transaction was disclosed on 1 April 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations31 total
6,505 sharesCommon StockSEC:0001193125-26-277509:0
29,000 sharesCommon StockSEC:0001193125-26-277509:1
7,434 shares@ US$18.35061.4% of flowCommon StockSEC:0000950170-25-050856:0
35,000 shares0Common StockSEC:0000950170-25-049763:0
53,500 shares@ US$0.670.4% of flowCommon StockSEC:0000950170-24-138447:0
51,110 shares@ US$26.355913.4% of flowCommon StockSEC:0000950170-24-124085:0
27,318 shares@ US$0.670.2% of flowCommon StockSEC:0000950170-24-115031:0
4,534 shares@ US$32.121.5% of flowCommon StockSEC:0000950170-24-041426:0
35,000 shares0Common StockSEC:0000950170-24-040151:0
90,900 shares@ US$0.670.6% of flowCommon StockSEC:0000950170-23-054850:0
69,438 shares@ US$7.224.9% of flowCommon StockSEC:0000950170-23-034518:0
21,846 shares@ US$7.221.5% of flowCommon StockSEC:0000950170-23-034518:1
155,324 shares@ US$32.0648.7% of flowCommon StockSEC:0000950170-23-034518:2
1,206 shares@ US$7.220.1% of flowCommon StockSEC:0000950170-23-034518:3
1,206 shares@ US$32.010.4% of flowCommon StockSEC:0000950170-23-034518:4
1,918 shares@ US$30.310.6% of flowCommon StockSEC:0000899243-23-010818:0
20,000 shares0Common StockSEC:0000899243-23-010138:0
9,106 shares@ US$0.670.1% of flowCommon StockSEC:0000899243-23-000973:0
4,500 shares@ US$0.670.0% of flowCommon StockSEC:0000899243-23-000237:0
18,211 shares@ US$0.670.1% of flowCommon StockSEC:0000899243-22-038538:0
15,000 shares0Common StockSEC:0000899243-22-013489:0
39,700 shares@ US$0.670.3% of flowCommon StockSEC:0000899243-21-050117
39,700 shares@ US$0.670.0008% mcap1.0% of flowCommon StockSEC:0000899243-21-050117:0
2,607 shares@ US$7.220.2% of flowCommon StockSEC:0000899243-21-049634
2,607 shares@ US$7.220.0006% mcap0.7% of flowCommon StockSEC:0000899243-21-049634:0
25 of 31 declarations
About Ciaramella Giuseppe
Giuseppe Ciaramella is President & CSO at Beam Therapeutics Inc. He is responsible for the strategic direction of the company and oversight of operations. His role is essential in guiding Beam's initiatives and supporting its mission.
